Biogen's efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China's InnoCare last year for $125 ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
17:02 Incerteza sobre acordo entre China e EUA pesa e soja recua em Chicago nesta terça-feira 12:51 Cotações da soja oscilam entre ganhos e perdas nesta terça-feira 12:10 No programa de Analisando sua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback